ArticleJournal of experimental & clinical cancer research : CR2025

HDAC2 as a therapeutic target in bladder cancer: insights into the altered epigenetic regulation and lysine lactylation.

Guanghui Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.